Allscripts-Misys Healthcare Solutions, which has a major presence in the Triangle, and its rival Eclipsys are combining in a $1.35 billion all-stock deal, the companies announced early Wednesday.
Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) will report its financial results for the three months and full year ended December 31, 2020 after the close of stock market hours on Thursday, ...
(a) Interest expense and other, net has been adjusted from the amounts presented in the statements of operations in order to remove the amortization of the fair value of the cash conversion option ...
RICHMOND, British Columbia--(BUSINESS WIRE)--KLAS Research named Allscripts (NASDAQ: MDRX) Sunrise™ as 2020 Best in KLAS - Global Acute Care EMR (Canada). Allscripts Sunrise Acute Care is a clinical ...
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions (NASDAQ: MDRX) today announced a strategic technology partnership with US Orthopedic Alliance (USOA), an orthopedic management services ...
Allscripts Partners with Opargo to Drive Improved Patient Care through Optimized Practice Management
CHICAGO, March 14, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX) announced a strategic partnership with Opargo focused on delivering integrated technology to improve health care efficiency ...
A new service from Allscripts seeks to support physicians’ population health efforts by helping refer patients to clinical trials and reducing the time and costs of trials, bringing treatments to the ...
LAS VEGAS, Dec. 8 -- Allscripts Chief Executive Officer Glen Tullman will host a webcast today, broadcasted live from the Allscripts Executive Summit in Las Vegas, to introduce two new innovations: ...
Allscripts Healthcare Solutions, Inc. MDRX is well-poised for growth in the coming quarters, backed by its strategic alliances over the past few months. A robust second-quarter 2022 performance and ...
Health IT company Allscripts' data analytics business is ramping up, delivering double-digit gains in the second quarter of 2021. The company's overall revenue was flat for the quarter, with a modest ...
In a step to advance their strategic partnership, Allscripts and NantHealth have invested significant sums of money in one another’s companies. Allscripts purchased a 10 percent equity stake in ...
Fourth quarter GAAP diluted EPS of $2.14; growth of 11% in non-GAAP diluted EPS to $0.20 Full year 2018 GAAP diluted EPS of $2.04; growth of 16% in non-GAAP diluted EPS to $0.72 Closed sale of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results